ArticlePediatric radiology2026
Diagnostic utility of magnetic resonance urography in pediatric ureteropelvic junction obstruction: evaluating changes in anteroposterior diameter of the renal pelvis following furosemide administration.
Article in Pediatric radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMagnetic resonance urography (MRU) with diuretic injection is increasingly used to evaluate pediatric ureteropelvic junction obstruction, providing anatomical and functional information without ionizing radiation.
objectiveTo analyze the increase in anteroposterior diameter of the renal pelvis following furosemide injection during MRU to determine a diagnostic cutoff. To assess whether this increase supports etiological diagnosis and whether magnetic resonance imaging (MRI) reliably detects crossing vessels. MATERIALS AND
methodsWe retrospectively included all children who underwent surgery for ureteropelvic junction obstruction at our institution between January 2010 and January 2023 and had preoperative MRU. For each patient, the increase in renal pelvis diameter after furosemide injection during MRU was measured on the obstructed and contralateral healthy sides. Measurements were compared to determine a pathological cutoff. The change in renal pelvis diameter was also compared according to etiology (intrinsic vs. extrinsic). The association between crossing vessels identified on MRI and intraoperative findings was also assessed.
resultsSeventy patients (median age 9) were included. The increase in renal pelvis diameter was significantly greater on the obstructed side compared to the contralateral side (P < 0.001). The optimal cutoff for predicting obstruction was 6 mm (sensitivity 68.6%, specificity 87.1%). No significant difference was found in the change in renal pelvis diameter according to etiology (P = 0.86). The association between crossing vessels identified on MRI and during surgery was significant (P < 0.001).
conclusionAn increase greater than 6 mm in renal pelvis diameter after furosemide injection during MRU could represent an additional diagnostic criterion for pediatric ureteropelvic junction obstruction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.